Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
Abstract Background Tenecteplase (TNK) offers promising efficacy and safety data for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) and pharmacological advantages over alteplase (rt-PA), justifying its gradual adoption as primary thrombolytic agent. At our tertiary care center, we tra...
Saved in:
| Main Authors: | Alexander Sekita, Gabriela Siedler, Jochen A. Sembill, Manuel Schmidt, Ludwig Singer, Bernd Kallmuenzer, Lena Mers, Anna Bogdanova, Stefan Schwab, Stefan T. Gerner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Neurological Research and Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42466-025-00388-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01) -
Tenecteplase is here: navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers, and pathways
by: Julian M. Burwell, et al.
Published: (2025-04-01) -
Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01) -
Tenecteplase Beyond 4.5 Hours in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Mohammad Aladawi, et al.
Published: (2025-05-01) -
Efficacy and Safety of Intravenous Thrombolysis Beyond 4.5 Hours in Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Muhammad Ahmad, et al.
Published: (2025-07-01)